DWIH Innovation Summit

Agenda

12 pm | Registration & Networking Lunch

1 pm | Welcome

• Oliver Schramm, Consul General of Germany in San Francisco 

1:10 pm | Expert Introductions — Challenges, Opportunities and Visions in the Life Sciences

• Melanie Ott, Director of the Gladstone Institute of Virology and Senior Vice President of Gladstone Institutes.
• Juliane Winkelmann, Director of the Institute of Neurogenomics at Helmholtz Munich, Chair of Human Genetics at Technical University Munich
• Opeoluwa O. Oyewole, Science Officer at the California Council on Science and Technology (CCST)
  
• Lothar Wieler, Head of the Digital Global Public Health department at the Hasso Plattner Institute
• Frauke Kraas, Professor of Urban and Social Geography at the Institute of Geography, University of Cologne

2:30 pm | Coffee Break & Networking

3:00 pm – 4:30 pm | Parallel Sessions

Session A: Data Exchange in Health – Opportunities and Challenges

Overview: This session will address the crucial role of data exchange in advancing healthcare, focusing on how secure, efficient data sharing can drive innovation, improve patient outcomes, and enable precision medicine. Participants will discuss best practices, policy frameworks, and technological solutions for enhancing data interoperability across systems and regions. 

• Juliane Winkelmann, Director of the Institute of Neurogenomics at Helmholtz Munich, Chair of Human Genetics at Technical University Munich  
• Sharmila Majumdar, UCSF Professor and Vice Chair for Research      
• Claus Glüer, Professor of Medical Physics, Christian-Albrechts-Universität zu Kiel
• Ying Lu, Professor of Biomedical Data Science, Stanford University
• Matthias Haury, Acting Executive Director and COO, Chan-Zuckerberg Imaging Institute 
• Bhupinder Bhullar, Managing Director and Co-Founder of Swiss Vault (Switzerland) Swiss Vault’s unique integration of software and hardware is redefining data infrastructure for AI, edge computing, and enterprise sectors. 

Moderator:  Paul Schmiedmayer, Lead Artificial Intelligence & Assistant Director of Digital Health, Stanford University  

Session B: Embracing Risk for Breakthrough Innovation in the Life Sciences

Overview: This session will examine the vital role of risk-taking in achieving transformative advancements in the life sciences. By exploring how public and private sectors manage high-risk, high-reward projects, participants will highlight the potential of daring initiatives to tackle significant health challenges.

• Widya Mulyasasmita, Co-Founder and Managing Partner at BEVC, a venture capital firm affiliated with Bakar Labs and the Bakar Ecosystem at UC Berkeley and UCSF
• Thomas Wechsler, Chair of the ASGCT Ethics Committee 
• Marianthi Fragkopoulou, CEO and Founder of Herado, Herado’s ALMAR dosimeter is positioned as a breakthrough in personal radiation protection 
• Sue Merrilees, Senior Director, Science Philanthropy Alliance

Moderator: Julia Schaletzky, Executive Director, Molecular Therapeutics Initiative, University of California, Berkeley  

Session C: From Treatment to Prevention: The Case for Precision in Public Health

Objective: Discuss the paradigm shift from personalized medicine to precision public health, focusing on preventive strategies and sustainable healthcare systems. 

• Daniela Caserotto-Leibert, Head of Cathay Ecosystem
• Lothar Wieler, Head of the Digital Global Public Health department at the Hasso Plattner Institute
• Shamala Hinrichsen, CEO and founder of Hanai, a social impact technology provider scaling healthcare while tracing its impact in vulnerable communities 
• Frauke Kraas, Professor of Urban and Social Geography at the Institute of Geography, University of Cologne

Moderator: Katherine Kim, Founder and CEO, Health Tequity 

4:30 PM – 5:00 PM | Coffee Break

5:00 PM – 6:00 PM | Results of the Parallel Sessions

6:00 PM – 6:15 PM | Next Steps

• Zahar Barth-Manzoori, Director DWIH San Francisco 
• Diego Rivas, Program Manager San Francisco, DFG 

 6:15 PM – 7:30 PM | Networking Reception